TNGX Tango Therapeutics | $31.56
+2.0% | 6/9/2026 | | Boost Price Target | $27.00 ➝ $66.00 | Buy | 00.00% | View details for HC Wainwright rating of Tango Therapeutics (NASDAQ:TNGX) on 6/9/2026 |
ZVRA Zevra Therapeutics | $13.66
+13.0% | 6/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 6/9/2026 |
BCDA BioCardia | $0.86
-6.6% | 6/9/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for HC Wainwright rating of BioCardia (NASDAQ:BCDA) on 6/9/2026 |
INCY Incyte | $103.23
+2.6% | 6/9/2026 | | Boost Price Target | $135.00 ➝ $140.00 | Buy | 00.00% | View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 6/9/2026 |
LYEL Lyell Immunopharma | $12.70
+3.2% | 6/9/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 6/9/2026 |
NGNE Neurogene | $28.81
+0.7% | 6/9/2026 | | Reiterated Rating | $70.00 | Buy | 00.00% | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 6/9/2026 |
NUVL Nuvalent | $123.25
+39.3% | 6/9/2026 | | Downgrade | $124.00 | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Nuvalent (NASDAQ:NUVL) on 6/9/2026 |
AMLX Amylyx Pharmaceuticals | $13.55
+4.2% | 6/8/2026 | | Reiterated Rating | $34.00 | Buy | 00.00% | View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 6/8/2026 |
ADCT ADC Therapeutics | $1.13
+15.6% | 6/8/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 6/8/2026 |
ATAI Atai Beckley | $3.89
+2.1% | 6/8/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Atai Beckley (NASDAQ:ATAI) on 6/8/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
CGEM Cullinan Therapeutics | $13.18
-0.8% | 6/8/2026 | | Reiterated Rating | $30.00 | Buy | 00.00% | View details for HC Wainwright rating of Cullinan Therapeutics (NASDAQ:CGEM) on 6/8/2026 |
FATE Fate Therapeutics | $1.90
-0.5% | 6/8/2026 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of Fate Therapeutics (NASDAQ:FATE) on 6/8/2026 |
MLTX MoonLake Immunotherapeutics | $17.80
-1.1% | 6/8/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 6/8/2026 |
ORIC Oric Pharmaceuticals | $8.00
+6.2% | 6/8/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Oric Pharmaceuticals (NASDAQ:ORIC) on 6/8/2026 |
PMN Promis Neurosciences | $9.74
+0.3% | 6/8/2026 | | Reiterated Rating | $18.00 | Buy | 00.00% | View details for HC Wainwright rating of Promis Neurosciences (NASDAQ:PMN) on 6/8/2026 |
STTK Shattuck Labs | $4.27
+9.5% | 6/8/2026 | | Reiterated Rating | $18.00 | Buy | 00.00% | View details for HC Wainwright rating of Shattuck Labs (NASDAQ:STTK) on 6/8/2026 |
TRX TRX Gold | $0.93
+0.5% | 6/8/2026 | | Reiterated Rating | $2.30 | Buy | 00.00% | View details for HC Wainwright rating of TRX Gold (NYSEAMERICAN:TRX) on 6/8/2026 |
TVRD Tvardi Therapeutics | $2.78
-2.5% | 6/8/2026 | | Initiated Coverage | $9.00 | Buy | 00.00% | View details for HC Wainwright rating of Tvardi Therapeutics (NASDAQ:TVRD) on 6/8/2026 |
LQDA Liquidia | $64.01
+0.2% | 6/5/2026 | | Boost Price Target | $67.00 ➝ $75.00 | Buy | 00.00% | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 6/5/2026 |
LQDA Liquidia | $64.01
+0.2% | 6/5/2026 | | Set Price Target | $28.00 | | 00.00% | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 6/5/2026 |
IPSEY IPSEN | $46.75
| 6/5/2026 | | Initiated Coverage | | Buy | 00.00% | View details for HC Wainwright rating of IPSEN (OTCMKTS:IPSEY) on 6/5/2026 |
RGNX REGENXBIO | $6.34
+3.4% | 6/5/2026 | | Lower Price Target | $30.00 ➝ $26.00 | Buy | 00.00% | View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 6/5/2026 |
TLPH Talphera | $0.82
-3.7% | 6/5/2026 | | Initiated Coverage | $3.00 | Buy | 00.00% | View details for HC Wainwright rating of Talphera (NASDAQ:TLPH) on 6/5/2026 |
INAB IN8bio | $1.45
+0.7% | 6/4/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 6/4/2026 |
VNDA Vanda Pharmaceuticals | $6.12
+3.0% | 6/4/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 6/4/2026 |
AXSM Axsome Therapeutics | $245.64
+4.5% | 6/4/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 6/4/2026 |
ALNY Alnylam Pharmaceuticals | $297.69
+1.9% | 6/4/2026 | | Reiterated Rating | $510.00 | Buy | 00.00% | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 6/4/2026 |
GUTS Fractyl Health | $0.66
-0.9% | 6/4/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for HC Wainwright rating of Fractyl Health (NASDAQ:GUTS) on 6/4/2026 |
RADX Radiopharm Theranostics | $4.25
+1.0% | 6/4/2026 | | Initiated Coverage | $6.00 | Buy | 00.00% | View details for HC Wainwright rating of Radiopharm Theranostics (NASDAQ:RADX) on 6/4/2026 |
MTSI MACOM Technology Solutions | $358.72
-0.9% | 6/3/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of MACOM Technology Solutions (NASDAQ:MTSI) on 6/3/2026 |
PBK PowerBank | $0.86
-6.5% | 6/3/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of PowerBank (NASDAQ:PBK) on 6/3/2026 |
ZBIO Zenas BioPharma | $18.42
+4.6% | 6/3/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Zenas BioPharma (NASDAQ:ZBIO) on 6/3/2026 |
SNDX Syndax Pharmaceuticals | $17.69
+4.3% | 6/3/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 6/3/2026 |
ORKA Oruka Therapeutics | $66.93
+4.5% | 6/3/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 6/3/2026 |
UPB Upstream Bio | $6.69
+3.7% | 6/3/2026 | | Initiated Coverage | $36.00 | Buy | 00.00% | View details for HC Wainwright rating of Upstream Bio (NASDAQ:UPB) on 6/3/2026 |
CELC Celcuity | $92.59
+5.9% | 6/3/2026 | | Lower Price Target | $185.00 ➝ $145.00 | Buy | 00.00% | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 6/3/2026 |
HIVE HIVE Digital Technologies | $3.74
-5.6% | 6/3/2026 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of HIVE Digital Technologies (NASDAQ:HIVE) on 6/3/2026 |
HRTX Heron Therapeutics | $0.40
-10.7% | 6/3/2026 | | Lower Price Target | $2.00 | Buy | 00.00% | View details for HC Wainwright rating of Heron Therapeutics (NASDAQ:HRTX) on 6/3/2026 |
KYTX Kyverna Therapeutics | $7.85
+1.8% | 6/3/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 6/3/2026 |
LEGN Legend Biotech | $33.49
+6.3% | 6/3/2026 | | Boost Price Target | $50.00 ➝ $65.00 | Buy | 00.00% | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 6/3/2026 |
June 12: $100 Turns Into $100,000? (Ad) The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast.
Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears. Click here to see how to get ahead of the SpaceX IPO |
LYEL Lyell Immunopharma | $12.70
+3.2% | 6/3/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 6/3/2026 |
PMI PMI | $0.32
+21.0% | 6/3/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of PMI (NYSEAMERICAN:PMI) on 6/3/2026 |
SLDB Solid Biosciences | $6.57
+2.5% | 6/3/2026 | | Boost Price Target | $20.00 ➝ $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 6/3/2026 |
UPB Upstream Bio | $6.69
+3.7% | 6/3/2026 | | Initiated Coverage | $36.00 | Buy | 00.00% | View details for HC Wainwright rating of Upstream Bio (NASDAQ:UPB) on 6/3/2026 |
URGN Urogen Pharma | $28.18
+3.4% | 6/3/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 6/3/2026 |
ZYME Zymeworks | $23.26
-2.8% | 6/3/2026 | | Reiterated Rating | $46.00 | Buy | 00.00% | View details for HC Wainwright rating of Zymeworks (NASDAQ:ZYME) on 6/3/2026 |
AKTS Aktis Oncology | $18.98
+0.1% | 6/2/2026 | | Boost Price Target | $33.00 ➝ $35.00 | Buy | 00.00% | View details for HC Wainwright rating of Aktis Oncology (NASDAQ:AKTS) on 6/2/2026 |
TVTX Travere Therapeutics | $48.57
+3.2% | 6/2/2026 | | Boost Price Target | $57.00 ➝ $67.00 | Buy | 00.00% | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 6/2/2026 |
MNPR Monopar Therapeutics | $60.63
+0.0% | 6/2/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Monopar Therapeutics (NASDAQ:MNPR) on 6/2/2026 |
CORT Corcept Therapeutics | $77.49
+5.7% | 6/2/2026 | | Boost Price Target | $75.00 ➝ $95.00 | Buy | 00.00% | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 6/2/2026 |
DRTS Alpha Tau Medical | $9.19
-1.0% | 6/2/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 6/2/2026 |
EWTX Edgewise Therapeutics | $34.06
-2.2% | 6/2/2026 | | Boost Price Target | $42.00 ➝ $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Edgewise Therapeutics (NASDAQ:EWTX) on 6/2/2026 |
FOCL FocalTherics | $4.52
-1.7% | 6/2/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for HC Wainwright rating of FocalTherics (NASDAQ:FOCL) on 6/2/2026 |
FULC Fulcrum Therapeutics | $3.52
+2.3% | 6/2/2026 | | Downgrade | $3.00 | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Fulcrum Therapeutics (NASDAQ:FULC) on 6/2/2026 |
IBRX ImmunityBio | $7.25
+1.1% | 6/2/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 6/2/2026 |
PRAX Praxis Precision Medicines | $250.33
-1.2% | 6/2/2026 | | Lower Price Target | $1,245.00 ➝ $1,201.00 | Buy | 00.00% | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 6/2/2026 |
RIGL Rigel Pharmaceuticals | $30.72
+2.1% | 6/2/2026 | | Reiterated Rating | $57.00 | Buy | 00.00% | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 6/2/2026 |
RZLT Rezolute | $3.90
-4.4% | 6/2/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 6/2/2026 |
TMC TMC the metals | $5.01
-2.0% | 6/2/2026 | | Reiterated Rating | $11.75 | Buy | 00.00% | View details for HC Wainwright rating of TMC the metals (NASDAQ:TMC) on 6/2/2026 |
RVMD Revolution Medicines | $149.55
+0.7% | 6/1/2026 | | Boost Price Target | $169.00 ➝ $195.00 | Buy | 00.00% | View details for HC Wainwright rating of Revolution Medicines (NASDAQ:RVMD) on 6/1/2026 |
COST Costco Wholesale | $968.59
-0.6% | 6/1/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Costco Wholesale (NASDAQ:COST) on 6/1/2026 |
IRTC iRhythm Technologies | $113.83
+6.2% | 6/1/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of iRhythm Technologies (NASDAQ:IRTC) on 6/1/2026 |
MLYS Mineralys Therapeutics | $24.18
+7.5% | 6/1/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 6/1/2026 |
CRDF Cardiff Oncology | $1.53
+2.0% | 6/1/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 6/1/2026 |
DRUG Bright Minds Biosciences | $67.80
+3.9% | 6/1/2026 | | Reiterated Rating | $145.00 | Buy | 00.00% | View details for HC Wainwright rating of Bright Minds Biosciences (NASDAQ:DRUG) on 6/1/2026 |
INO Inovio Pharmaceuticals | $1.10
+0.9% | 6/1/2026 | | Lower Price Target | $3.00 ➝ $2.50 | Neutral | 00.00% | View details for HC Wainwright rating of Inovio Pharmaceuticals (NASDAQ:INO) on 6/1/2026 |
INVA Innoviva | $22.54
+0.9% | 6/1/2026 | | Reiterated Rating | $46.00 | Buy | 00.00% | View details for HC Wainwright rating of Innoviva (NASDAQ:INVA) on 6/1/2026 |
JBIO Jade Biosciences | $15.22
+1.6% | 6/1/2026 | | Boost Price Target | $45.00 ➝ $55.00 | Buy | 00.00% | View details for HC Wainwright rating of Jade Biosciences (NASDAQ:JBIO) on 6/1/2026 |
KRYS Krystal Biotech | $309.75
+2.6% | 6/1/2026 | | Reiterated Rating | $310.00 | Buy | 00.00% | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 6/1/2026 |
OCS Oculis | $10.98
+2.5% | 6/1/2026 | | Lower Price Target | $47.00 ➝ $26.00 | Buy | 00.00% | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 6/1/2026 |
RNTX Rein Therapeutics | $0.92
-3.0% | 6/1/2026 | | Lower Price Target | $10.00 ➝ $8.00 | Buy | 00.00% | View details for HC Wainwright rating of Rein Therapeutics (NASDAQ:RNTX) on 6/1/2026 |
SPRB Spruce Biosciences | $49.03
-0.6% | 6/1/2026 | | Lower Price Target | $200.00 ➝ $150.00 | Buy | 00.00% | View details for HC Wainwright rating of Spruce Biosciences (NASDAQ:SPRB) on 6/1/2026 |
DPRO Draganfly | $5.98
-6.9% | 5/29/2026 | | Initiated Coverage | $14.00 | Buy | 00.00% | View details for HC Wainwright rating of Draganfly (NASDAQ:DPRO) on 5/29/2026 |
CPRX Catalyst Pharmaceuticals | $31.34
+0.2% | 5/28/2026 | | Downgrade | $35.00 ➝ $31.50 | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 5/28/2026 |
ABEO Abeona Therapeutics | $5.45
+1.3% | 5/28/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 5/28/2026 |
BBIO BridgeBio Pharma | $67.68
+0.5% | 5/28/2026 | | Reiterated Rating | $110.00 | Buy | 00.00% | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 5/28/2026 |
CORT Corcept Therapeutics | $77.49
+5.7% | 5/28/2026 | | Boost Price Target | $75.00 ➝ $95.00 | Buy | 00.00% | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 5/28/2026 |
ELTX Elicio Therapeutics | $14.20
+4.8% | 5/28/2026 | | Reiterated Rating | $17.00 | Buy | 00.00% | View details for HC Wainwright rating of Elicio Therapeutics (NASDAQ:ELTX) on 5/28/2026 |
MDWD MediWound | $14.30
+0.6% | 5/28/2026 | | Reiterated Rating | $36.00 | Buy | 00.00% | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 5/28/2026 |
MPLT Maplight Therapeutics | $29.27
-0.6% | 5/28/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Maplight Therapeutics (NASDAQ:MPLT) on 5/28/2026 |
PGEN Precigen | $3.71
+3.9% | 5/28/2026 | | Boost Price Target | $11.00 ➝ $14.00 | Buy | 00.00% | View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 5/28/2026 |
UNH UnitedHealth Group | $412.57
+1.5% | 5/27/2026 | | Set Price Target | $492.00 | | 00.00% | View details for HC Wainwright rating of UnitedHealth Group (NYSE:UNH) on 5/27/2026 |
UNCY Unicycive Therapeutics | $7.27
+9.2% | 5/27/2026 | | Reiterated Rating | $22.00 | Buy | 00.00% | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 5/27/2026 |
ANRO Alto Neuroscience | $21.15
+15.9% | 5/27/2026 | | Reiterated Rating | $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Alto Neuroscience (NYSE:ANRO) on 5/27/2026 |
LEGN Legend Biotech | $33.49
+6.3% | 5/27/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 5/27/2026 |
IONS Ionis Pharmaceuticals | $74.58
+1.4% | 5/27/2026 | | Reiterated Rating | $125.00 | Buy | 00.00% | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 5/27/2026 |
FRVO Fervo Energy | $33.56
-1.2% | 5/27/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Fervo Energy (NASDAQ:FRVO) on 5/27/2026 |
WDAY Workday | $140.23
-2.5% | 5/27/2026 | | Set Price Target | $140.00 | | 00.00% | View details for HC Wainwright rating of Workday (NASDAQ:WDAY) on 5/27/2026 |
DTIL Precision BioSciences | $6.86
+1.3% | 5/27/2026 | | Reiterated Rating | $60.00 | Buy | 00.00% | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 5/27/2026 |
RCAT Red Cat | $11.49
-7.8% | 5/27/2026 | | Initiated Coverage | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Red Cat (NASDAQ:RCAT) on 5/27/2026 |
Read this warning immediately (Ad) Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776.
One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. Read Porter Stansberry's full breakdown and protect your wealth now |
TGTX TG Therapeutics | $43.37
+5.9% | 5/27/2026 | | Reiterated Rating | $70.00 | Buy | 00.00% | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 5/27/2026 |
PPTA Perpetua Resources | $22.66
-1.1% | 5/26/2026 | | Boost Price Target | $41.00 ➝ $43.50 | Buy | 00.00% | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 5/26/2026 |
VYGR Voyager Therapeutics | $3.43
+1.8% | 5/26/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 5/26/2026 |
GEVO Gevo | $1.50
-5.1% | 5/26/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 5/26/2026 |
LBRX LB Pharmaceuticals | $29.27
-0.4% | 5/26/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of LB Pharmaceuticals (NASDAQ:LBRX) on 5/26/2026 |
MGTX MeiraGTx | $9.21
+1.3% | 5/26/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of MeiraGTx (NASDAQ:MGTX) on 5/26/2026 |
BWAY Brainsway | $14.43
+0.1% | 5/26/2026 | | Reiterated Rating | $15.00 ➝ $17.00 | Buy | 00.00% | View details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 5/26/2026 |
RLAY Relay Therapeutics | $14.09
+3.1% | 5/26/2026 | | Boost Price Target | $25.00 ➝ $28.00 | Buy | 00.00% | View details for HC Wainwright rating of Relay Therapeutics (NASDAQ:RLAY) on 5/26/2026 |
BHVN Biohaven | $11.11
-0.1% | 5/26/2026 | | Reiterated Rating | $10.00 | Neutral | 00.00% | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 5/26/2026 |
CING Cingulate | $4.65
+2.6% | 5/26/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Cingulate (NASDAQ:CING) on 5/26/2026 |
